![Frontiers | Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics Frontiers | Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics](https://www.frontiersin.org/files/Articles/517828/fmicb-11-00135-HTML/image_m/fmicb-11-00135-g001.jpg)
Frontiers | Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
![Vaccines | Free Full-Text | Prospects and Challenges in the Development of Universal Influenza Vaccines Vaccines | Free Full-Text | Prospects and Challenges in the Development of Universal Influenza Vaccines](https://www.mdpi.com/vaccines/vaccines-08-00361/article_deploy/html/images/vaccines-08-00361-g001.png)
Vaccines | Free Full-Text | Prospects and Challenges in the Development of Universal Influenza Vaccines
![A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial | Nature Medicine A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-020-1118-7/MediaObjects/41591_2020_1118_Fig1_HTML.png)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial | Nature Medicine
![Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial - The Lancet Infectious Diseases Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/7c0d7ba9-81c6-42c8-af68-6d61627d61f5/gr1_lrg.jpg)
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial - The Lancet Infectious Diseases
![Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice - ScienceDirect Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X21008331-ga1.jpg)
Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice - ScienceDirect
![NIAID unveils strategic plan for developing a universal influenza vaccine | National Institutes of Health (NIH) NIAID unveils strategic plan for developing a universal influenza vaccine | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2018/20180228-flue-criteria.jpg?itok=5CVXmyei×tamp=1519825602)
NIAID unveils strategic plan for developing a universal influenza vaccine | National Institutes of Health (NIH)
![No more annual flu shot? Scripps Research and collaborators find new target for universal influenza vaccine | Scripps Research No more annual flu shot? Scripps Research and collaborators find new target for universal influenza vaccine | Scripps Research](https://www.scripps.edu/_files/images/news-and-events/large-release-images/2021/20211223-ward-universal-influenza-vaccine-920x500.png)